Chronic Lymphocytic Leukaemia Clinical Trial
Official title:
A Retrospective Observational Study to Evaluate the Clinical Outcomes and Routine Management of Patients With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland
The primary objective of this study is to evaluate the effectiveness of idelalisib and rituximab in adults with chronic lymphocytic leukaemia (CLL) in a real world setting
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06357754 -
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Secondary Malignancy
|
||
| Completed |
NCT02933320 -
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02267590 -
Tissue Collection for Biomarkers Determining Resistance to Ibrutinib
|
N/A | |
| Completed |
NCT01832597 -
Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
|
N/A | |
| Terminated |
NCT01127542 -
RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial
|
Phase 2 | |
| Recruiting |
NCT04763083 -
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
|
Phase 1 | |
| Completed |
NCT01597219 -
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
|
Phase 2 | |
| Withdrawn |
NCT00504491 -
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia
|
Phase 2 | |
| Terminated |
NCT01446900 -
R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma
|
Phase 2 | |
| Recruiting |
NCT01678430 -
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment
|
Phase 3 | |
| Terminated |
NCT00751296 -
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
|
Phase 2 | |
| Completed |
NCT01659255 -
Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL
|
Phase 1 | |
| Recruiting |
NCT04728893 -
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
|
Phase 2 | |
| Completed |
NCT01805375 -
A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
|
Phase 1 | |
| Completed |
NCT00457782 -
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
|
Phase 1 | |
| Completed |
NCT00292760 -
A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion
|
Phase 2 |